4 Biotech Stocks Ready to Crush the Market in 2018

The year 2017 has been quite impressive one for the biotech sector as evident from the 19.4% gain registered so far by the Nasdaq Biotechnology Index. This is surely welcome news for investors since the industry suffered a decline of 19.2% last year.